Surgical Robotics Technology’s Post

Bigger is Not Better! Significant Milestone for Stereotaxis and GenesisX! Stereotaxis just achieved a significant milestone, securing CE mark approval in Europe and submitting an FDA 510(k) application for their new GenesisX surgical robot. This cutting-edge system is a prime example of how medtech companies are moving towards surgical robotics platforms that are more accessible, smaller, and easier to implement and deploy, simplifying hospital integration and advancing patient care. GenesisX is a refined iteration of Stereotaxis' Genesis robotic magnetic navigation (RMN) system. It breaks down previous barriers by designing a more compact and efficient setup. Gone are the days of complex structural modifications and hefty installations. GenesisX uses smaller magnets and needs only standard power outlets, making it accessible for more hospitals. With these improvements, GenesisX promises swift, responsive performance and seamless workflow. As Stereotaxis aims for a full launch in 2025, the company plans to gather real-world data, secure additional regulatory approvals, and prepare the supply chain. This innovation opens doors for broader adoption in electrophysiology and endovascular procedures, bringing advanced robotic solutions to more patients. #MedTech #SurgicalRobotics #HealthcareInnovation

Read this article to learn how Medcrypt's Guardian & RTI's Connext ensures that medical device manufacturers can effectively secure their devices and meet FDA requirements. Authors include: Felix Adusei and Om Mahida at Medcrypt and Akkshaj S. at RTI. Take a look here: https://lnkd.in/gEudmk5c #robotics #roboticsurgery #healthcare #medicaldevices

Check out this week's News We're Watching from the regulatory and commercial team Medtech Insight. Citeline Citeline Regulatory Citeline Commercial #FDA #approvals #voicebiomarkers #robotics #medtech #healthcare #AI

🤖⚕️#Roboticsurgery can be a much safer a reliable process if all components are tested thoroughly. Here is how we did it for a medical giant: #medicaldevices #medtech #testengineering https://hubs.ly/Q02FdtdR0

Microbot Medical is revolutionizing healthcare with the first single-use endovascular robotic system, transforming procedures and expanding global access. https://bit.ly/3IM9VDY #MedTech #Endovascular

I was told I was mean. I was told I was unfair. I was told I was biased. That's okay. But I was asked specifically "Why are you so tough on JNJ and Medtronic and their surgical robotic programs?" So I've decided to do an open answer to this - anyone can read it. And it may surprise you as to why... it will not be what most people think. Read why here >> https://lnkd.in/e2_iyRKb #surgicalrobotics #roboticsurgery

𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗕𝗮𝗿𝗿𝗶𝗲𝗿𝘀 𝗶𝗻 𝗘𝗻𝗱𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗖𝗮𝗿𝗲! Microbot Medical has taken a monumental step forward with the 𝗙𝗗𝗔 𝘀𝘂𝗯𝗺𝗶𝘀𝘀𝗶𝗼𝗻 of the 𝗟𝗜𝗕𝗘𝗥𝗧𝗬® 𝗘𝗻𝗱𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗥𝗼𝗯𝗼𝘁𝗶𝗰 𝗦𝘆𝘀𝘁𝗲𝗺—the world’s 𝗳𝗶𝗿𝘀𝘁 𝘀𝗶𝗻𝗴𝗹𝗲-𝘂𝘀𝗲, 𝗳𝘂𝗹𝗹𝘆 𝗱𝗶𝘀𝗽𝗼𝘀𝗮𝗯𝗹𝗲 𝗿𝗼𝗯𝗼𝘁𝗶𝗰 𝘀𝘆𝘀𝘁𝗲𝗺 for endovascular procedures. What does this mean for healthcare? 🔹 𝗘𝗻𝗵𝗮𝗻𝗰𝗲𝗱 𝘀𝗮𝗳𝗲𝘁𝘆 through single-use technology. 🔹 𝗦𝘁𝗿𝗲𝗮𝗺𝗹𝗶𝗻𝗲𝗱 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀 with robotic precision. 🔹 A 𝗽𝗮𝗿𝗮𝗱𝗶𝗴𝗺 𝘀𝗵𝗶𝗳𝘁 in peripheral vascular care. This cutting-edge advancement follows a successful multi-center trial, ensuring safety and performance in real-world scenarios. What could this innovation mean for your practice or patients?  Join the conversation and explore the future of robotic care in endovascular procedures. 🔗 https://lnkd.in/gRrk8MGb #HealthcareInnovation #RoboticSurgery #MedicalTechnology #Endovascular #MedicalDevices #HealthcareProfessionals

#TheReprocessingReport: https://hubs.ly/Q02r6kh40 While investments in cutting-edge robotic surgical systems surge, sterile processing departments often find themselves without resources. We explore how strategic provisioning of tools and equipment can invigorate reprocessing departments. #PureProcessing #SPD #SterileProcessing #CentralProcessing #MDR #TheReprocessingReport

How important is growth in annual procedural volume per system for manufacturers.? In the last few days CMR Surgical announced  they had  a cumulative total of 25,000 procedures while SS Innovations announced passing the 2,000 mark. Based on this limited information and trawling through available information I have tried to put together comparative procedural adoption lines. Intuitive did not start talking about procedural volumes before 2007 in their annual reports.  I have also been able to included data from Asensus Surgical which prior to its take over by KARL STORZ was also providing  procedural information. MicroPort MedBot are also a public company but it is too soon to have any meaningful data. These numbers may not be 100% accurate but I believe they are directionally correct, What is interesting is that the lines seem to be pretty consistent and similar. One could argue that the followers should have a procedural adoption faster than the first mover as the market has already been created. The fact that it is not the case shows the complexity of launching and supporting surgical robots. The challenge SS Innovations will be in 2025 can it get into the 50 to 60 procedures per system  and for CMR Surgical and Asensus Surgical can they get in the 80 to 100 range. Intuitive in 2023 were close to 300 procedures per system as another reference point, Hopefully as time goes on we will get a clearer picture

Outrage ❗ ❗❗ How dare I predict that Intuitive will have these ludicrous market shares and Johnson & Johnson and Medtronic will not be the dominant player in soft tissue surgical robotics? 👇 I have explained in details how I get to these numbers right here>> https://lnkd.in/dAjjyh7M Those "Others" include Medicaroid CMR Surgical Virtual Incision Vicarious Surgical Inc. Distalmotion MicroPort MedBot and many others... You all need to know the reality of what it means to get to that magic 10% or 15% market share against this Goliath called #intuitive. These are not sutures or stapler !!!!! This is the single most complex capital equipment sales in the history of medical device - Period. #medtronic #hugoras #ottava #johnsonandjohnson #medicaroid #hinotori #microport #toumai #MIRA #Versius